Preliminary evaluation of a phase I clinical study of quelamycin.
D000505:Alopecia / Q000139:chemically induced; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009503:Neutropenia / Q000139:chemically induced
C018376:quelamycin; D004317:Doxorubicin